Sr. Director - Global Diagnostics Partnerships

Chester, Maryland, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree and a minimum of 4 years of relevant experience in Business Development or partnership functions within the diagnostics industry. Preferred qualifications include an advanced degree such as a Ph.D. or MS/MBA, and deep understanding of the diagnostic ecosystem along with a strong network within it.

Responsibilities

The Sr. Director, Global Diagnostics Partnerships will deliver strategic guidance to cross-functional partners and business units, identify and create new partnership opportunities to advance Lilly’s patient identification goals, cultivate relationships with key diagnostic providers, develop novel partnership models, define internal processes for alignment, oversee global partnerships, support sourcing and acquisition activities, maintain knowledge of the diagnostic landscape, and function as the ‘face of Lilly’ to global diagnostic partners. They will also support innovation and launch readiness, and ensure compliance and effectiveness of partnerships.

Skills

diagnostic partnerships

strategic planning

biomarker development

collaborative relationship management

global healthcare

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free